NewslettersMammary Cell NewsUncategorizedInhibitors of PD-1/PD-L1 and ERK1/2 Impede the Proliferation of Receptor Positive and Triple-Negative Breast Cancer Cell LinesBy Justin.choi - July 5, 20210151The effect of combined PD-1/PD-L1 and extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitor treatment was investigated of cell growth and intracellular impact of breast cancer cell lines.[Journal of Cancer Research and Clinical Oncology] 7992332 {7992332:MCW65KF6} apa 50 1 164162 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article